summary
Introduced
11/05/2019
11/05/2019
In Committee
11/06/2019
11/06/2019
Crossed Over
Passed
Dead
12/31/2020
12/31/2020
Introduced Session
133rd General Assembly
Bill Summary
To enact section 3902.50 of the Revised Code to cap cost-sharing for prescription insulin drugs.
AI Summary
This bill enacts Section 3902.50 of the Revised Code to cap the cost-sharing for prescription insulin drugs at $100 per 30-day supply, regardless of the amount or type of insulin needed. Cost-sharing refers to the out-of-pocket expenses, such as copayments, coinsurance, and deductibles, that a covered person must pay under a health benefit plan. The bill applies to health plan issuers that provide coverage for prescription insulin drugs, ensuring that individuals with diabetes have access to affordable insulin.
Committee Categories
Health and Social Services
Sponsors (29)
Kristin Boggs (D)*,
Beth Liston (D)*,
Janine Boyd (D),
Richard Brown (D),
Randi Clites (D),
Erica Crawley (D),
Jeffrey Crossman (D),
Sedrick Denson (D),
Tavia Galonski (D),
Timothy Ginter (R),
Paula Hicks-Hudson (D),
Brigid Kelly (D),
David Leland (D),
Michele Lepore-Hagan (D),
Mary Lightbody (D),
Adam Miller (D),
Joe Miller (D),
Jessica Miranda (D),
Michael O'Brien (D),
John Patterson (D),
Allison Russo (D),
Michael Sheehy (D),
Mike Skindell (D),
Kent Smith (D),
Lisa Sobecki (D),
Fred Strahorn (D),
Terrence Upchurch (D),
Casey Weinstein (D),
Thomas West (D),
Last Action
House Health Liston – 1st Hearing, Sponsor (11:00 2/18/2020 Room 116) (on 02/18/2020)
bill text
bill summary
Loading...
bill summary
Loading...
bill summary
Loading...